[FOR RELEASE May 10, 2019 China Biologic Reports Financial Results for the First Quarter of 2019 —1Q19 Total Sales Up 15.4% YoY in USD terms, or 22.3% YoY in RMB terms; Net Income Up 19.3% YoY to $37.7 Million; Non-GAAP Adjusted Net Income Up 14.3% YoY in RMB terms — BEIJING, China – May 10, 2019 – F]
[FOR RELEASE May 10, 2019 China Biologic Reports Financial Results for the First Quarter of 2019 —1Q19 Total Sales Up 15.4% YoY in USD terms, or 22.3% YoY in RMB terms; Net Income Up 19.3% YoY to $37.7 Million; Non-GAAP Adjusted Net Income Up 14.3% YoY in RMB terms — BEIJING, China – May 10, 2019 – F]
[CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. 2019 EQUITY INCENTIVE PLAN 1. This Plan permits the Administrator to grant Options, Restricted Shares, Restricted Share Units, Share Appreciation Rights, and Other Share-Based Awards in order to retain, attract and motivate Employees, Directors and Consultants ]
[CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. 2019 EQUITY INCENTIVE PLAN 1. This Plan permits the Administrator to grant Options, Restricted Shares, Restricted Share Units, Share Appreciation Rights, and Other Share-Based Awards in order to retain, attract and motivate Employees, Directors and Consultants ]
[Joint Filing Agreement [Remainder of this page has been left intentionally blank.] BEACHHEAD HOLDINGS LIMITED CENTURIUM CAPITAL PARTNERS 2018, L.P. CENTURIUM CAPITAL PARTNERS 2018 GP LTD., GENERAL PARTNER CENTURIUM CAPITAL PARTNERS 2018, GP LTD. CENTURIUM CAPITAL 2018 CO-INVEST, L.P. CENTURIUM CAPIT]
[Joint Filing Agreement [Remainder of this page has been left intentionally blank.] BEACHHEAD HOLDINGS LIMITED CENTURIUM CAPITAL PARTNERS 2018, L.P. CENTURIUM CAPITAL PARTNERS 2018 GP LTD., GENERAL PARTNER CENTURIUM CAPITAL PARTNERS 2018, GP LTD. CENTURIUM CAPITAL 2018 CO-INVEST, L.P. CENTURIUM CAPIT]
[FOR RELEASE March 6, 2019 China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2018 --4Q18 Total Sales Up 27.5% YoY in USD terms, or 33.5% YoY in RMB terms; --FY18 Total Sales Up 26.1% YoY in USD terms, or 23.5% YoY in RMB terms; -- Issues Forecast for FY19 – --Board of Di]
[FOR RELEASE March 6, 2019 China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2018 --4Q18 Total Sales Up 27.5% YoY in USD terms, or 33.5% YoY in RMB terms; --FY18 Total Sales Up 26.1% YoY in USD terms, or 23.5% YoY in RMB terms; -- Issues Forecast for FY19 – --Board of Di]
[] [1.1 THE COMPANIES LAW (2016 REVISION) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. (Adopted by Special Resolution passed on 21 July 2017 THE COMPANIES LAW (2016 REVISION) OF THE CAYMAN ISLANDS]
[] [1.1 THE COMPANIES LAW (2016 REVISION) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. (Adopted by Special Resolution passed on 21 July 2017 THE COMPANIES LAW (2016 REVISION) OF THE CAYMAN ISLANDS]
